Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

Clinical trial NCT07457918 · RECRUITING

Trial details

NCT number: NCT07457918
Sponsor: Verrica Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Common Warts (Verruca Vulgaris)Common Warts Human Papilloma Virus (HPV)Warts

Start date: 2026-03-11
Primary completion: 2028-04-30
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.